Meeting
2013 ASCO Annual Meeting
The impact of diabetes on HCC.
Authors
Suzanne Graef
The University of Birmingham, School of Cancer Sciences, Birmingham, United Kingdom
Suzanne Graef , Sarah Berhane , Mabel Joey Teng , Anna Skowronska , Philip James Johnson
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Hepatobiliary Cancer
Citation
J Clin Oncol 31, 2013 (suppl; abstr 4029)
DOI
10.1200/jco.2013.31.15_suppl.4029
Abstract #
4029
Poster Bd #
21
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
The impact of diabetes mellitus and metformin on survival of patients with advanced pancreatic cancer receiving chemotherapy.
First Author: Do-Youn Oh
Poster
2013 Gastrointestinal Cancers Symposium
Hepatocellular cancer tumor growth and metabolic risk factors.
First Author: Rebecca Miksad
Poster
2012 Gastrointestinal Cancers Symposium
Prevalence of risk factors among patients with hepatocellular carcinoma (HCC) and the general population in an employer group database.
First Author: QuynhChau Diem Doan
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Comparison of the treatment effect between lenvatinib and atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma in pathologically diagnosed metabolic dysfunction–associated steatotic liver disease.
First Author: Hirokazu Takahashi